XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,143 | -9.8% | 183,205 | -0.4% | 0.24% | -23.2% |
| Q1 2024 | $7,922 | -20.9% | 184,015 | -15.3% | 0.31% | -23.1% |
| Q4 2023 | $10,010 | +128.1% | 217,320 | +69.1% | 0.40% | +95.6% |
| Q3 2023 | $4,389 | -21.3% | 128,487 | -11.3% | 0.21% | -15.2% |
| Q2 2023 | $5,578 | +305.7% | 144,877 | +277.2% | 0.24% | +273.8% |
| Q1 2023 | $1,375 | -4.2% | 38,407 | +5.5% | 0.06% | -18.8% |
| Q4 2022 | $1,436 | -99.9% | 36,416 | -19.5% | 0.08% | -19.2% |
| Q3 2022 | $1,633,000 | +103.4% | 45,246 | +71.4% | 0.10% | +65.0% |
| Q2 2022 | $803,000 | +117.6% | 26,404 | +118.7% | 0.06% | +150.0% |
| Q1 2022 | $369,000 | – | 12,074 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |